rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Sensata Technologies Holding plc

ST · NYSE

Health CareLife-science toolsNot moving yetAutonomy

ST stood above a rising 150-day average in 47 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 7.0% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 2
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$1.0M
Insider sales, 12 months
$9.3M
Officials’ trades on record
8
Institutions holding
436 (+45)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 47 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$7.5M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

8 disclosed lines: House 6, Senate 2, executive 0; 4 people.

WhoDidAmountTraded
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k12 May 2026filed 8 Jun 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k11 May 2026filed 8 Jun 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k7 May 2026filed 8 Jun 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k1 May 2026filed 8 May 2026
Peter Meijer House: U.S. House ClerkMI03sold$1k–$15k16 Feb 2021filed 16 Mar 2021
James M. Inhofe Senate: U.S. Senate eFDSenatorsold$50k–$100k28 Jun 2018filed 12 Jul 2018
James M. Inhofe Senate: U.S. Senate eFDSenatorbought$50k–$100k19 Jun 2017filed 3 Jul 2017
Thomas MacArthur House: U.S. House ClerkNJ03soldjoint$15k–$50k27 Jan 2015filed 5 Mar 2015

Insiders

Buy orders, 12 months1
Sale orders, 12 months10
Buyers · sellers1 · 3
WhoDidSharesTraded
Lynne J. CaljouwEVP, Chief HR Officersold2,723at $50.3512 Jun 2026filed 16 Jun 2026
David K. StottEVP, General Counselsold6,335at $47.4020 May 2026filed 22 May 2026
Lynne J. CaljouwEVP, Chief HR Officersold2,913at $34.717 Apr 2026filed 9 Apr 2026
Lynne J. CaljouwEVP, Chief HR Officersold2,480at $34.5018 Mar 2026filed 20 Mar 2026
Schuckmann Stephan VonCEObought15,150at $33.116 Mar 2026filed 10 Mar 2026
Lynne J. CaljouwEVP, Chief HR Officersold2,496at $37.5312 Feb 2026filed 17 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders436+45 on the quarter
New · exited94 · 48
Reported value$6.9B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202613,603,325$649.4M+149,837+1.1%
Jupiter Topco LLCnew · filed 14 Aug 202610,925,289$521.6M+10,925,289
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20267,702,384$367.7M-43,455−0.6%
DIMENSIONAL FUND ADVISORS LPadded · filed 11 Aug 20267,483,244$357.2M+92,014+1.2%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20266,555,888$313.0M+15,043+0.2%
FULLER & THALER ASSET MANAGEMENT, INC.reduced · filed 12 Aug 20265,724,546$273.3M-1,137,845−16.6%
STATE STREET CORPadded · filed 7 Aug 20264,758,142$227.2M+3,581+0.1%
BARROW HANLEY MEWHINNEY & STRAUSS LLCreduced · filed 12 Aug 20263,792,500$181.1M-357,477−8.6%
Woodline Partners LPreduced · filed 14 Aug 20263,451,383$164.8M-439,336−11.3%
FMR LLCadded · filed 13 Aug 20263,133,057$149.6M+2,162,541+222.8%
31 Mar 2023 – 30 Jun 2026
309370431Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Alice Martins McIntosh Company insiderEVP, President of Industrials · last 1 Oct 20260 · 0
Patrick Norton Hertzke Company insiderEVP, Growth & Transformation · last 2 Sep 20260 · 0
Andrew Charles Lynch Company insiderEVP & Chief Financial Officer · last 21 Jul 20260 · 0
Lynne J. Caljouw Company insiderEVP, Chief HR Officer · last 12 Jun 20260 · 7
Ali John Mirshekari Company insiderDirector · last 9 Jun 20262 · 3
Andrew C. Teich Company insiderDirector · last 9 Jun 20261 · 0
Constance Ellen Skidmore Company insiderDirector · last 9 Jun 20260 · 0
Daniel Black Company insiderDirector · last 9 Jun 20260 · 0
John P. Absmeier Company insiderDirector · last 9 Jun 20260 · 0
Jugal K. Vijayvargiya Company insiderDirector · last 9 Jun 20260 · 0
Laurie Schupmann Company insiderDirector · last 9 Jun 20260 · 0
Lorraine A. Bolsinger Company insiderDirector · last 9 Jun 20260 · 0

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202529.3%
Operating profit marginFY 2025 · to 31 Dec 20256.4%
Free cash flow marginFY 2025 · to 31 Dec 202513.2%
Return on capital employedFY 2025 · to 31 Dec 20254.0%
Cash conversionFY 2024 · to 31 Dec 2024429%
Debt to equityFY 2025 · to 31 Dec 20251.02×
Interest coverFY 2024 · to 31 Dec 20240.96×
Research spendFY 2025 · to 31 Dec 20253.6%
Share count trendFY 2025 · to 29 Jan 2026-0.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$573.0M
Free cash flowFY 2025 · to 31 Dec 2025$490.3M

Analyst forecasts

No analyst forecasts yet.